Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The performance of latent class analysis for clustering multiple long-term conditions is robust to the impact of high prevalence conditions.

Journal of clinical epidemiology·2026
Same author

Muscle Ageing and Sarcopenia Study (MASS) Lifecourse: a valuable resource for understanding skeletal muscle ageing.

GeroScience·2026
Same author

Prioritising and ranking methodological uncertainties in the design, conduct, and analysis of trials aiming to improve health outcomes for those living with multiple long-term conditions: A protocol for a modified Delphi study.

Journal of multimorbidity and comorbidity·2026
Same author

What barriers need to be removed to incorporate resistance exercise into the lives of older adults with long-term diabetes and prefrailty? A deductive framework analysis using the Capability, Opportunity, Motivation and Behaviour (COM-B) behavioural science model.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

[Detection of faecal blood outside organised screening programmes: the vital role of medical biologists].

Annales de biologie clinique·2026
Same author

Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients' receiving haemodialysis with or at risk of renal cachexia.

Research involvement and engagement·2026
Same journal

Severe tricuspid regurgitation is a congestion-driven cardiorenal disease: A longitudinal study defining a right heart failure phenotype.

International journal of cardiology·2026
Same journal

Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.

International journal of cardiology·2026
Same journal

Effectiveness of a new diagnostic algorithm for the diagnosis of unexplained syncope in patients with hypertrophic cardiomyopathy.

International journal of cardiology·2026
Same journal

The predictive role of the FIB-4 index in identifying arrhythmic risk among patients with nonischemic dilated cardiomyopathy.

International journal of cardiology·2026
Same journal

Beyond arrhythmias: Exploring heart failure in arrhythmogenic cardiomyopathy.

International journal of cardiology·2026
Same journal

Corrigendum to "First-in-human study of the K-Clip™ transcatheter annular repair system for severe functional tricuspid regurgitation" [International Journal of Cardiology 390(2023) / IJCA 131174].

International journal of cardiology·2026
See all related articles

Related Experiment Videos

Predicting mortality using two renal function estimation methods in hospitalised stroke patients.

Louise F Porter, Miles D Witham, Callum G Fraser

    International Journal of Cardiology
    |November 7, 2008
    PubMed
    Summary
    This summary is machine-generated.

    The Cockcroft-Gault equation and the MDRD method both predict mortality in acute stroke patients. Cockcroft-Gault showed stronger predictive power for mortality and length of stay.

    Related Experiment Videos

    Area of Science:

    • Nephrology
    • Neurology
    • Clinical Epidemiology

    Background:

    • Estimating renal function is crucial for managing patients with acute stroke.
    • The Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations are commonly used to estimate kidney function.
    • The comparative prognostic value of these equations in acute stroke patients is not well-established.

    Purpose of the Study:

    • To compare the prognostic abilities of the MDRD and Cockcroft-Gault equations for estimating renal function in patients with acute stroke.
    • To assess the independent predictive power of these equations for mortality and length of stay.

    Main Methods:

    • A cohort study was conducted with 1287 patients admitted to a Scottish tertiary care teaching hospital with acute stroke.
    • Cox regression analysis, corrected for other prognostic variables, was used to evaluate mortality prediction.
    • Spearman's rank test was employed to assess the prediction of length of stay.

    Main Results:

    • Both the MDRD and Cockcroft-Gault equations independently predicted mortality in acute stroke patients.
    • A 1 ml/min reduction in estimated GFR by MDRD was associated with a 1.0% increase in mortality risk.
    • A 1 ml/min reduction in creatinine clearance by Cockcroft-Gault was associated with a 1.7% increase in mortality risk.
    • The Cockcroft-Gault equation showed a weak but significant prediction for length of stay (r=0.066, p=0.02).

    Conclusions:

    • Both the MDRD and Cockcroft-Gault equations are valuable tools for predicting early and late mortality in acute stroke patients.
    • The Cockcroft-Gault equation demonstrated greater predictive power for mortality and length of stay in this specific patient population.
    • These findings highlight the importance of renal function estimation in stroke patient prognostication.